Owners, developers see silver lining in health care real estate
Health care real estate has survived the nation’s weak economy better than most sectors, and some owners and developers
think it’s positioned to thrive.
Health Care & Life Sciences
Articles
WellPoint CFO says insurance ‘mega-mergers’ unlikely
WellPoint Inc. chief financial officer Wayne DeVeydt said President Obama’s Federal Trade Commission is unlikely to approve
mergers among the biggest insurers.
Lilly awards pay increases to top executives
Eli Lilly and Co. CEO John Lechleiter’s total compensation increased $4.1 million in 2009.
Cardinal Health laying off 49 at local warehouse
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more
effective April 3.
WellPoint: More employers involved in provider talks
Employer activism is on the rise when it comes to keeping hospitals honest in their negotiations with health insurers.
Executives at Indianapolis-based WellPoint say more employers are airing their displeasure when hospital
systems ask for double-digit reimbursement increases.
Health care venture capital swoons in Indy, holds steady statewide
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009.
Mississippi settles Zyprexa suit against Lilly for over $18M
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
Hill-Rom profit up 40 percent
Batesville maker of hospital equipment meets analysts’ expectations, then raises full-year profit forecast.
UPDATE: Glasscock retirement marks WellPoint’s maturation
Larry Glasscock will step down March 1 as WellPoint CEO Angela Braly takes over leadership of the company’s board. She replaced
Glasscock as CEO on June 1, 2007.
Chairman Glasscock retiring from WellPoint board
Larry Glasscock will retire as chairman of WellPoint Inc.’s board, the Indianapolis-based health insurer said early Wednesday.
Company CEO Angela Braly will assume the position March 1.
Indy without Lilly, the 500?
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
Q&A: Dr. Kristine Courtney
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
Health firms still attracting venture capital
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009. That trend hit Indianapolis,
but the rest of the state actually saw an increase.
Dow AgroSciences profit falls despite revenue increase
Indianapolis-based Dow AgroSciences said Tuesday it posted a profit of $69 million in the fourth quarter, down 19 percent
from the prior year because of increased research and development spending and higher administrative expenses. Revenue was
up 17 percent.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
City of Greenwood might fund launch of insulin maker
Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin,
a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal
that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.
St. Vincent to buy Care Group, city’s largest cardiology practice
St. Vincent Health is near an agreement to take over The Care Group LLC, the city’s largest independent physician practice
and largest cardiology group in the nation.
Health care reform will go on regardless of federal government
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
Federal rule tied to electronic medical records panned
The government has erected a high fence around a pot of $27 billion available to doctors and hospitals that successfully
computerize their patient records by next year, sparking complaints.
Lilly’s profits fall, miss analyst expectations
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.